Scholars Central

Conference abstractPublished 1 Sep 2015

Quantitative proteomics for epigenetics: MS-based analysis of the histone post-translational modifications for basic and clinical research

Authors: Tiziana Bonaldi, R Noberini, M Soldi, G Sigismondo, A Cuomo

European Institute of Oncology, Italy; Italian Institute of Technology, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Chromatin is a highly dynamic, well-organized and yet ill-defined protein-DNA-RNA structure that controls various DNAdependent processes. A large number of site-specific reversible and irreversible post-translational modifications of histones (hPTMs) contribute to the maintenance and modulation of chromatin plasticity, gene activation and a variety of other biological processes and disease states. Abnormalities in hPTM patterns, upstream or downstream of DNA methylation are a critical event in cancer initiation and progression as a consequence of the aberrant expression or irregular activity of the enzymes responsible for setting or removing such modifications during the transition from physiological state to tumor. For instance, genetic alterations in various histone deacetylases and demethylases loci are frequently observed in human cancers. As such, hPTMs can represent powerful biomarkers for patient stratification and to predict a specific response to epigenetic drugs. Nevertheless, a comprehensive description of how histone modifications are altered in transformed cells is missing. It is therefore crucial to accurately detect and quantify hPTMs linked with diseased states to shed light on these mechanisms and to exploit them for prognostic, diagnostic and therapeutical purposes. Recent achievements made Mass Spectrometry (MS) and quantitative Proteomics excellent tools within the arsenal of analytical strategies aiming at understanding how histone variants/PTMs and their specific interactors mediate the structural-functional state of chromatin. Our team has contributed to this common effort by setting up distinct quantitative MSproteomics approaches combined with various biochemical methods of enrichment of chromatin and extra-chromatin proteins to facilitate the investigation of the complexity and plasticity of gene expression regulation. The talk will offer an overview of the MSproteomics strategies developed in our group to gain novel unconventional insights into chromatin biology highlighting approaches based on the clinical applications of the abovementioned MS techniques to the analysis of breast cancer clinical samples.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Proteomics & Bioinformatics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Tiziana Bonaldi”
  • BylineArticles whose byline prints “R Noberini”
  • BylineArticles whose byline prints “M Soldi”
  • BylineArticles whose byline prints “G Sigismondo”
  • BylineArticles whose byline prints “A Cuomo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels